Abbott files for marketing approval of novel ICU sedative and analgesic compound Jan. 11, 1999 No Comments
Sibia Neurosciences completes phase I study of SIB-1553A and initiates phase II study Jan. 11, 1999 No Comments
Pharmacokinetic profile of edaravone, a novel antioxidant from Mitsubishi Chemical Jan. 8, 1999 No Comments
Creative BioMolecules licenses neurotrophic protein from Cambridge NeuroScience Jan. 8, 1999 No Comments
Histamine H3 antagonist ciproxifan shows positive behavioral effects in animal models Jan. 8, 1999 No Comments
Mexiletine effectively controls spasmodic torticollis in treatment-refractory patients Jan. 8, 1999 No Comments
Fujisawa obtains Japanese marketing rights to Zeneca's atypical antipsychotic quetiapine Jan. 7, 1999 No Comments
RSS